Es gab 50 kürzliche Insider-Transaktionen für eFFECTOR Therapeutics, Inc. (EFTR), darunter 44 Käufe und 4 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $2.22M und die gesamten Insider-Verkäufe auf $127.33K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Ehrlich Christopher B, Loewy Caroline M, Klencke Barbara. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — EFTR
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-06-13 |
Ehrlich Christopher B |
Director |
RSU-Zuteilung |
800 |
$1.38 |
$1.1K |
800 |
| 2024-06-13 |
Loewy Caroline M |
Director |
RSU-Zuteilung |
800 |
$1.38 |
$1.1K |
800 |
| 2024-06-13 |
Klencke Barbara |
Director |
RSU-Zuteilung |
800 |
$1.38 |
$1.1K |
800 |
| 2024-06-13 |
Gallagher Brian M. Jr. |
Director |
RSU-Zuteilung |
800 |
$1.38 |
$1.1K |
800 |
| 2024-06-13 |
Bhatt Elizabeth |
Director |
RSU-Zuteilung |
800 |
$1.38 |
$1.1K |
800 |
| 2024-06-13 |
Harrington-smith Kristen |
Director |
RSU-Zuteilung |
800 |
$1.38 |
$1.1K |
800 |
| 2024-05-15 |
Worland Stephen T |
Chief Executive Officer |
RSU-Zuteilung |
1,806 |
$1.68 |
$3.04K |
12,494 |
| 2024-05-15 |
Byrnes Michael |
Chief Financial Officer |
RSU-Zuteilung |
1,387 |
$1.68 |
$2.33K |
3,117 |
| 2024-02-19 |
Worland Stephen T |
Chief Executive Officer |
RSU-Zuteilung |
80,000 |
$11.32 |
$905.6K |
80,000 |
| 2024-02-19 |
Ehrlich Christopher B |
Director |
RSU-Zuteilung |
2,000 |
$11.32 |
$22.64K |
2,000 |
| 2024-02-19 |
Loewy Caroline M |
Director |
RSU-Zuteilung |
2,000 |
$11.32 |
$22.64K |
2,000 |
| 2024-02-19 |
Byrnes Michael |
Chief Financial Officer |
RSU-Zuteilung |
40,000 |
$11.32 |
$452.8K |
40,000 |
| 2024-02-19 |
Klencke Barbara |
Director |
RSU-Zuteilung |
2,000 |
$11.32 |
$22.64K |
2,000 |
| 2024-02-19 |
Gallagher Brian M. Jr. |
Director |
RSU-Zuteilung |
2,000 |
$11.32 |
$22.64K |
2,000 |
| 2024-02-19 |
Bhatt Elizabeth |
Director |
RSU-Zuteilung |
2,000 |
$11.32 |
$22.64K |
2,000 |
| 2024-02-19 |
Harrington-smith Kristen |
Director |
RSU-Zuteilung |
2,000 |
$11.32 |
$22.64K |
2,000 |
| 2024-02-19 |
Warner Douglas J |
Chief Medical Officer |
RSU-Zuteilung |
25,000 |
$11.32 |
$283K |
25,000 |
| 2023-11-27 |
Sr One Capital Management, Llc |
10 Percent Owner |
Informierter Verkauf |
178,585 |
$0.61 |
$108.31K |
1,821,415 |
| 2023-11-15 |
Worland Stephen T |
Chief Executive Officer |
RSU-Zuteilung |
5,979 |
$0.50 |
$2.97K |
267,204 |
| 2023-11-15 |
Byrnes Michael |
Chief Financial Officer |
RSU-Zuteilung |
4,524 |
$0.50 |
$2.25K |
43,271 |
| 2023-09-09 |
Loewy Caroline M |
Director |
Veräußerung |
- |
- |
- |
9,047 |
| 2023-09-09 |
Loewy Caroline M |
Director |
RSU-Zuteilung |
40,000 |
$0.65 |
$25.84K |
40,000 |
| 2023-08-11 |
Worland Stephen T |
Chief Executive Officer |
Optionsausübung (Verkauf) |
33,799 |
$0.52 |
$17.58K |
- |
| 2023-06-22 |
Ehrlich Christopher B |
Director |
RSU-Zuteilung |
20,000 |
$0.82 |
$16.3K |
20,000 |
| 2023-06-22 |
Smither John W |
Director |
RSU-Zuteilung |
20,000 |
$0.82 |
$16.3K |
20,000 |
| 2023-06-22 |
Klencke Barbara |
Director |
RSU-Zuteilung |
20,000 |
$0.82 |
$16.3K |
20,000 |
| 2023-06-22 |
Gallagher Brian M. Jr. |
Director |
RSU-Zuteilung |
20,000 |
$0.82 |
$16.3K |
20,000 |
| 2023-06-22 |
Bhatt Elizabeth |
Director |
RSU-Zuteilung |
20,000 |
$0.82 |
$16.3K |
20,000 |
| 2023-06-22 |
Harrington-smith Kristen |
Director |
RSU-Zuteilung |
20,000 |
$0.82 |
$16.3K |
20,000 |
| 2023-05-15 |
Worland Stephen T |
Chief Executive Officer |
RSU-Zuteilung |
6,401 |
$0.46 |
$2.94K |
227,426 |
| 2023-05-15 |
Byrnes Michael |
Chief Financial Officer |
RSU-Zuteilung |
4,863 |
$0.46 |
$2.23K |
38,747 |
| 2023-01-20 |
Ehrlich Christopher B |
Director |
RSU-Zuteilung |
35,938 |
- |
- |
35,938 |
| 2023-01-20 |
Smither John W |
Director |
RSU-Zuteilung |
36,875 |
- |
- |
36,875 |
| 2023-01-20 |
Klencke Barbara |
Director |
RSU-Zuteilung |
28,125 |
- |
- |
28,125 |
| 2023-01-20 |
Gallagher Brian M. Jr. |
Director |
RSU-Zuteilung |
50,938 |
- |
- |
50,938 |
| 2023-01-20 |
Bhatt Elizabeth |
Director |
RSU-Zuteilung |
30,000 |
- |
- |
30,000 |
| 2023-01-20 |
Harrington-smith Kristen |
Director |
RSU-Zuteilung |
28,125 |
- |
- |
28,125 |
| 2023-01-17 |
Worland Stephen T |
Chief Executive Officer |
RSU-Zuteilung |
1,000,000 |
- |
- |
1,000,000 |
| 2023-01-17 |
Byrnes Michael |
Chief Financial Officer |
RSU-Zuteilung |
500,000 |
- |
- |
500,000 |
| 2023-01-17 |
Gandhi Mayank |
Chief Business Officer |
RSU-Zuteilung |
150,000 |
- |
- |
150,000 |
| 2023-01-17 |
Warner Douglas J |
Chief Medical Officer |
RSU-Zuteilung |
250,000 |
- |
- |
250,000 |
| 2022-11-15 |
Worland Stephen T |
Chief Executive Officer |
RSU-Zuteilung |
6,047 |
$0.47 |
$2.83K |
221,025 |
| 2022-11-15 |
Byrnes Michael |
Chief Financial Officer |
RSU-Zuteilung |
4,651 |
$0.47 |
$2.18K |
33,884 |
| 2022-10-04 |
Ehrlich Christopher B |
Director |
Informierter Kauf |
346 |
$0.57 |
$197.22 |
35,213 |
| 2022-09-26 |
Ehrlich Christopher B |
Director |
Informierter Kauf |
18,867 |
$0.55 |
$10.38K |
34,867 |
| 2022-09-26 |
Gandhi Mayank |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-09-26 |
Gandhi Mayank |
Chief Business Officer |
RSU-Zuteilung |
500,000 |
$0.57 |
$282.5K |
500,000 |
| 2022-08-08 |
Warner Douglas J |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-08-08 |
Warner Douglas J |
Chief Medical Officer |
RSU-Zuteilung |
618,160 |
- |
- |
618,160 |
| 2022-08-03 |
Presidio Management Group X Llc |
10 Percent Owner |
Informierter Verkauf |
1,796 |
$0.80 |
$1.44K |
127,569 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall